Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey

被引:4845
作者
Ford, ES
Giles, WH
Dietz, WH
机构
[1] Ctr Dis Control & Prevent, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 287卷 / 03期
关键词
D O I
10.1001/jama.287.3.356
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context The Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) highlights the importance of treating patients with the metabolic syndrome to prevent cardiovascular disease. Limited information is available about the prevalence of the metabolic syndrome in the United States, however. Objective To estimate the prevalence of the metabolic syndrome in the United States as defined by the ATP III report. Design, Setting, and Participants Analysis of data on 8814 men and women aged 20 years or older from the Third National Health and Nutrition Examination Survey (1988-1994), a cross-sectional health survey of a nationally representative sample of the noninstitutionalized civilian US population. Main Outcome Measures Prevalence of the metabolic syndrome as defined by ATP III (greater than or equal to3 of the following abnormalities): waist circumference greater than 102 cm in men and 88 cm in women; serum triglycerides level of at least 150 mg/dL (1.69 mmol/L); high-density lipoprotein cholesterol level of less than 40 mg/dL (1.04 mmol/L) in men and 50 mg/dL (1.29 mmol/L) in women; blood pressure of at least 130/85 mm Hg; or serum glucose level of at least 110 mg/dL (6.1 mmol/L). Results The unadjusted and age-adjusted prevalences of the metabolic syndrome were 21.8% and 23.7%, respectively. The prevalence increased from 6.7% among participants aged 20 through 29 years to 43.5% and 42.0% for participants aged 60 through 69 years and aged at least 70 years, respectively. Mexican Americans had the highest age-adjusted prevalence of the metabolic syndrome (31.9%). The age-adjusted prevalence was similar for men (24.0%) and women (23.4%). However, among African Americans, women had about a 57% higher prevalence than men did and among Mexican Americans, women had about a 26% higher prevalence than men did. Using 2000 census data, about 47 million US residents have the metabolic syndrome. Conclusions These results from a representative sample of US adults show that the metabolic syndrome is highly prevalent. The large numbers of US residents with the metabolic syndrome may have important implications for the health care sector.
引用
收藏
页码:356 / 359
页数:4
相关论文
共 24 条
  • [11] Cardiovascular morbidity and mortality associated with the metabolic syndrome
    Isomaa, B
    Almgren, P
    Tuomi, T
    Forsén, B
    Lahti, K
    Nissén, M
    Taskinen, MR
    Groop, L
    [J]. DIABETES CARE, 2001, 24 (04) : 683 - 689
  • [12] Risk stratification in hypertension: New insights from the Framingham Study
    Kannel, WB
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (01) : 3S - 10S
  • [13] Insulin resistance: definition and consequences
    Lebovitz, HE
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2001, 109 : S135 - S148
  • [14] Development of the multiple metabolic syndrome in the ARIC cohort: Joint contribution of insulin, BMI, and WHR
    Liese, AD
    MayerDavis, EJ
    Tyroler, HA
    Davis, CE
    Keil, U
    Duncan, BB
    Heiss, G
    [J]. ANNALS OF EPIDEMIOLOGY, 1997, 7 (06) : 407 - 416
  • [15] Risk variable clustering in the insulin resistance syndrome - The Framingham Offspring Study
    Meigs, JB
    DAgostino, RB
    Wilson, PWF
    Cupples, LA
    Nathan, DM
    Singer, DE
    [J]. DIABETES, 1997, 46 (10) : 1594 - 1600
  • [16] Invited commentary: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors
    Meigs, JB
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 152 (10) : 908 - 911
  • [17] The continuing epidemic of obesity in the United States
    Mokdad, AH
    Serdula, MK
    Dietz, WH
    Bowman, BA
    Marks, JS
    Koplan, JP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (13): : 1650 - 1651
  • [18] *NIH, 2001, 013670 NIH
  • [19] Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance - The Da Qing IGT and diabetes study
    Pan, XR
    Li, GW
    Hu, YH
    Wang, JX
    Yang, WY
    An, ZX
    Hu, ZX
    Lin, J
    Xiao, JZ
    Cao, HB
    Liu, PA
    Jiang, XG
    Jiang, YY
    Wang, JP
    Zheng, H
    Zhang, H
    Bennett, PH
    Howard, BV
    [J]. DIABETES CARE, 1997, 20 (04) : 537 - 544
  • [20] Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects
    Rantala, AO
    Kauma, H
    Lilja, M
    Savolainen, MJ
    Reunanen, A
    Kesäniemi, YA
    [J]. JOURNAL OF INTERNAL MEDICINE, 1999, 245 (02) : 163 - 174